• Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

bioMmune Technologies Inc

+ Add to Watchlist


0.2600 CAD 0.0300 13.04%

As of 11:21:34 ET on 09/10/2014.

Snapshot for bioMmune Technologies Inc (IMU)

Open: 0.2600 Day's Range: 0.2600 - 0.2600 Volume: 50,000
Previous Close: 0.2300 52wk Range: 0.1600 - 0.3900 1-Yr Rtn: +62.50%

Stock Chart for IMU

No chart data available.
  • IMU:CN 0.2600
  • 1D
  • 1M
  • 1Y
Interactive IMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMU

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 6.42
Shares Outstanding (M) 24.67
30 Day Average Volume 4,908
Price/Book (mrq) 3.1596
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMU

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for IMU

bioMmune Technologies Inc is a private British Columbia company that was formed to commercially exploit a number of patents and patent applications that surround three technologies for the treatment of cancer. The first technology involves the discovery of HDACi's (Histone Deacetylase), The second technology deals with Calcium Channels, and the third technology is called CD74.

Robin B Hutchison "Rob"ChairmanReinhard GabathulerPresident/CEO
Judi DallingCFO/Secretary
More Company Profile & Key Executives for IMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil